These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 7031891)

  • 1. [Luteinizing hormone-releasing hormone and its analogue investigation and application (author's transl)].
    Ge LJ; He YY
    Sheng Li Ke Xue Jin Zhan; 1981 Feb; 12(2):113-8. PubMed ID: 7031891
    [No Abstract]   [Full Text] [Related]  

  • 2. [Radioimmunoassay of luteinizing hormone releasing hormone (author's transl)].
    Oshima I; Musa K; Yamamoto S
    Rinsho Byori; 1975 Nov; 23(11):834-8. PubMed ID: 1107628
    [No Abstract]   [Full Text] [Related]  

  • 3. [Structure and function of luliberin (author's transl)].
    Rzeszotarska B; Kozłowska I
    Postepy Biochem; 1980; 26(3):411-42. PubMed ID: 6782561
    [No Abstract]   [Full Text] [Related]  

  • 4. A clinician's guide to the use of gonadotropin-releasing hormone analogues in women.
    Moghissi KS
    Medscape Womens Health; 2000 Jan; 5(1):5. PubMed ID: 10792849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum luteinizing hormone, follicle-stimulating hormone and oestradiol pattern in women undergoing pituitary suppression with different gonadotrophin-releasing hormone analogue protocols for assisted reproduction.
    Manna C; Rahman A; Sbracia M; Pappalardo S; Mohamed EI; Linder R; Nardo LG
    Gynecol Endocrinol; 2005 Apr; 20(4):188-94. PubMed ID: 16019360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The significance of clinical application of LH-releasing hormone test in patients with amenorrhea (author's transl)].
    Zhang LZ
    Zhonghua Fu Chan Ke Za Zhi; 1981 Oct; 16(4):220-4. PubMed ID: 7044719
    [No Abstract]   [Full Text] [Related]  

  • 7. [Peptid contraception--new principles for family planning].
    Nillius SJ
    Lakartidningen; 1981 Aug; 78(34):2845-8. PubMed ID: 7033692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective treatment of metastatic MDA-MB-435 human estrogen-independent breast carcinomas with a targeted cytotoxic analogue of luteinizing hormone-releasing hormone AN-207.
    Chatzistamou L; Schally AV; Nagy A; Armatis P; Szepeshazi K; Halmos G
    Clin Cancer Res; 2000 Oct; 6(10):4158-65. PubMed ID: 11051271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful pregnancy following gonadotrophin-releasing hormone analogue treatment in a previously infertile bitch.
    Tsumagari S; Ishinazaka T; Watanabe G; Taya K; Ishii M
    J Small Anim Pract; 2006 Apr; 47(4):213-5. PubMed ID: 16573765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uncommon course of carcinoma of the prostate after radical prostatectomy and luteinizing hormone-releasing hormone analogue therapy.
    Pauer W; Eckerstorfer GM
    J Urol; 1998 Oct; 160(4):1432-3. PubMed ID: 9751377
    [No Abstract]   [Full Text] [Related]  

  • 11. [Inhibin (author's transl)].
    Fujii T
    Horumon To Rinsho; 1982 May; 30(5):433-9. PubMed ID: 7049443
    [No Abstract]   [Full Text] [Related]  

  • 12. Ovulation induction with pulsatile gonadotropin-releasing hormone (GnRH) or gonadotropins in a case of hypothalamic amenorrhea and diabetes insipidus.
    Georgopoulos NA; Markou KB; Pappas AP; Protonatariou A; Vagenakis GA; Sykiotis GP; Dimopoulos PA; Tzingounis VA
    Gynecol Endocrinol; 2001 Dec; 15(6):421-5. PubMed ID: 11826765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of arginine residues in the biological function of peptides and proteins (author's transl)].
    Farbiszewski R; Gabryel H
    Postepy Biochem; 1980; 26(3):291-311. PubMed ID: 6782559
    [No Abstract]   [Full Text] [Related]  

  • 14. [Ovulation induction with gonadotropin in patients with thalassemia pretreated with pulsatile GnRH: outcome].
    Vizziello G; Carone D; Caroppo E; Vitti A; Pasquadibisceglie A; D'Amato G
    Minerva Ginecol; 2004 Oct; 56(5):485-7. PubMed ID: 15531866
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of oral contraceptives on assisted reproductive technology [corrected] cycles.
    Kolibianakis EM; Venetis CA; Tarlatzis BC
    Curr Opin Obstet Gynecol; 2007 Jun; 19(3):244-7. PubMed ID: 17495640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of gonadotropic releasing hormone for ovulating the rabbit model.
    Foote RH; Simkin ME
    Lab Anim Sci; 1993 Aug; 43(4):383-5. PubMed ID: 8231104
    [No Abstract]   [Full Text] [Related]  

  • 17. Endocrine modifications associated with final oocyte maturation with gonadotropin-releasing hormone agonists vs. human chorionic gonadotropin in women undergoing intrauterine insemination.
    Díaz I; Guillén A; Pacheco A; Requena A; Garcia-Velasco JA
    J Reprod Med; 2008 Jan; 53(1):33-9. PubMed ID: 18251359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ovulation inducing drugs].
    J Gynecol Obstet Biol Reprod (Paris); 2005 May; 34(3 Pt 2):4S5-12. PubMed ID: 16108118
    [No Abstract]   [Full Text] [Related]  

  • 19. The pharmacology and the potential applications of GnRH antagonists.
    Loy RA
    Curr Opin Obstet Gynecol; 1994 Jun; 6(3):262-8. PubMed ID: 8038414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted doxorubicin-containing luteinizing hormone-releasing hormone analogue AN-152 inhibits the growth of doxorubicin-resistant MX-1 human breast cancers.
    Bajo AM; Schally AV; Halmos G; Nagy A
    Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3742-8. PubMed ID: 14506166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.